Osher Van De Voorde Investment Management Amgen Inc Transaction History

Osher Van De Voorde Investment Management

$465 Million
Q4 2024

A detailed history of Osher Van De Voorde Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Osher Van De Voorde Investment Management holds 66,801 shares of AMGN stock, worth $19.6 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares

66,801

Previous 66,449 0.53%

Holding current value

$19.6 Million

Previous $21.4 Million 18.68%

% of portfolio

3.75%

Previous 4.65%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$258.78 - $328.31 $91,090 - $115,565	352 Added 0.53%	66,801 $17.4 Million
Q3 2024 Oct 08, 2024	SELL	$309.38 - $337.38 $151,596 - $165,316	-490 Reduced 0.73%	66,449 $21.4 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $456,922 - $555,280	-1,739 Reduced 2.53%	66,939 $20.9 Million
Q1 2024 Apr 09, 2024	SELL	$268.87 - $324.56 $1.82 Million - $2.19 Million	-6,752 Reduced 8.95%	68,678 $19.5 Million
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $1.21 Million - $1.37 Million	4,740 Added 6.71%	75,430 $21.7 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $5,466 - $6,786	25 Added 0.04%	70,690 $19 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $1.48 Million - $1.75 Million	6,901 Added 10.82%	70,665 $15.7 Million
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $194,179 - $236,672	-860 Reduced 1.33%	63,764 $15.4 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $1.99 Million - $2.53 Million	-8,688 Reduced 11.85%	64,624 $0
Q3 2022 Oct 05, 2022	SELL	$224.46 - $253.15 $142,532 - $160,750	-635 Reduced 0.86%	73,312 $16.5 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $165,188 - $183,825	-716 Reduced 0.96%	73,947 $18 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $462,878 - $512,065	2,111 Added 2.91%	74,663 $18.1 Million
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $3.44 Million - $3.93 Million	17,280 Added 31.26%	72,552 $16.3 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $423,478 - $496,156	1,995 Added 3.74%	55,272 $11.8 Million
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $235,215 - $260,953	1,007 Added 1.93%	53,277 $13 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $242,991 - $283,167	1,095 Added 2.14%	52,270 $13 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $242,345 - $288,590	1,120 Added 2.24%	51,175 $11.8 Million
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $200,625 - $223,112	855 Added 1.74%	50,055 $12.7 Million
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $28,682 - $35,197	-145 Reduced 0.29%	49,200 $11.6 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $8.99 Million - $11.9 Million	49,345 New	49,345 $10 Million

Others Institutions Holding AMGN

# of Institutions

3,095

Shares Held

405M

Call Options Held

7.57M

Put Options Held

7.12M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Osher Van De Voorde Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Osher Van De Voorde Investment Management with notifications on news.

Account

Osher Van De Voorde Investment Management Amgen Inc Transaction History